Royal Bank Of Canada Cuts Ardent Health (NYSE:ARDT) Price Target to $12.00

Ardent Health (NYSE:ARDT) had its price target lowered by research analysts at Royal Bank Of Canada from $13.00 to $12.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target suggests a potential upside of 19.46% from the stock’s current price.

ARDT has been the subject of several other research reports. Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th. UBS Group increased their target price on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Wall Street Zen raised shares of Ardent Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 16th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $14.12.

Ardent Health Trading Down 1.0%

Shares of Ardent Health stock traded down $0.10 on Thursday, hitting $10.04. 91,627 shares of the company’s stock traded hands, compared to its average volume of 450,636. Ardent Health has a one year low of $7.71 and a one year high of $15.48. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. The company has a fifty day moving average of $9.59 and a two-hundred day moving average of $9.24. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of 10.56, a price-to-earnings-growth ratio of 2.44 and a beta of 0.76.

Ardent Health (NYSE:ARDT) last issued its earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, sell-side analysts expect that Ardent Health will post 1.11 earnings per share for the current year.

Insider Buying and Selling at Ardent Health

In other Ardent Health news, CFO Alfred Lumsdaine acquired 10,000 shares of Ardent Health stock in a transaction dated Friday, June 5th. The stock was purchased at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the acquisition, the chief financial officer directly owned 329,183 shares of the company’s stock, valued at $2,900,102.23. This represents a 3.13% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.90% of the company’s stock.

Hedge Funds Weigh In On Ardent Health

Hedge funds have recently added to or reduced their stakes in the stock. Goldentree Asset Management LP lifted its holdings in shares of Ardent Health by 99.7% in the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock valued at $20,302,000 after purchasing an additional 1,150,000 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Ardent Health by 1,684.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after acquiring an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Ardent Health by 75.6% in the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after purchasing an additional 703,739 shares during the last quarter. Bridgeway Capital Management LLC lifted its position in shares of Ardent Health by 108.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock valued at $8,358,000 after purchasing an additional 491,961 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC purchased a new position in Ardent Health during the third quarter worth about $6,377,000.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.